Scientists sound alarm over threat of untreatable gonorrhea in United States

February 9, 2012 By Bobbi Nodell
A stained sample of gonorrhea bacteria detected in a urinary tract specimen. Credit: CDC

(Medical Xpress) -- Researchers are continuing to sound the alarm on the growing threat of multi-drug resistant gonorrhea in the United States, according to a perspective  in the Feb. 9 issue of the New England Journal of Medicine.

In July of 2011, the U.S. Centers for Disease Control and Prevention released “Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates - United States, 2000-2010,” which signaled the potential for resistance to the cephalosporins, the last line of defense for treating .

The New England Journal of Medicine piece,  “The Emerging Threat of Untreatable Gonococcal Infection,” by Gail A. Bolan, director of the Division of STD Prevention at  the Centers for Disease Control and Prevention in Atlanta, P. Frederick Sparling, professor emeritus at  the University of North Carolina, Chapel Hill, and Judith N. Wasserheit, professor and vice chair of  the Department of Global Health at the University of Washington in Seattle, issues an urgent call to action to halt the continued increases in drug-resistant gonorrhea.

“It is time to sound the alarm,” said co-author Wasserheit. “Though there is no evidence yet of treatment failures in the United States, trends in decreased susceptibility coupled with a history of emerging resistance and reported treatment failures in other countries point to a likelihood of failures on the horizon and a need for urgent action.”

According to the article, gonorrhea is the second most commonly reported communicable disease in the , with an estimated incidence of more than 600,000 cases annually. It disproportionately affects some populations such as minorities who are marginalized because of race, ethnic group or sexual orientation.

Scientists note that Neisseria gonorrhoeae has always readily developed resistance to antimicrobial agents: it became resistant to sulfanilamide in the 1940s, penicillins and tetracyclines in the 1980s, and fluoroquinolones by 2007.  The treatment options recommended by the CDC are now limited to third-generation cephalosporins.

But the effectiveness of cephalosporins for treating gonorrhea has been decreasing rapidly. Through CDC’s Gonococcal Isolate Surveillance Project , researchers are seeing a 17-fold increase in elevated minimum inhibitory concentrations (MICs) -- a measure of drug susceptibility. MICs for oral cefixime went from 0.1 percent in 2006 to 1.7 percent in the first six months of 2011.

In the past, when the prevalence of antimicrobial resistance in the Gonococcal Isolate Surveillance Project  exceeded 5 percent, national treatment recommendations were changed to focus on other effective drugs. But currently, there are no other drugs.

The most prominent increases in drug susceptibility to gonorrhea continue to be among men who have sex with men, and in the West, according to the authors. They wrote that these geographic and demographic patterns are worrisome because they mirror those observed during the emergence of fluoroquinolone-resistant N. gonorrhoeae.

Scientists are calling on a collective effort from physicians, drug companies, and health care providers to help stop the emergence and spread of resistant gonorrhea.

“Investing in rebuilding our defenses against gonococcal infections now, with involvement of the health care, public health, and research communities, is paramount if we are to control the spread and reduce the consequences of cephalosporin-resistant strains,” the scientists wrote.

Explore further: Rise of antibiotic-resistant gonorrhea needs urgent action

Related Stories

Rise of antibiotic-resistant gonorrhea needs urgent action

September 19, 2011
Gonorrhea is evolving into a scourge resistant to most antibiotics, and urgent action is needed to combat this public health threat, states an editorial in CMAJ (Canadian Medical Association Journal).

Scientists discover first gonorrhea strain resistant to all available antibiotics

July 11, 2011
An international research team has discovered a strain of gonorrhea resistant to all currently available antibiotics. This new strain is likely to transform a common and once easily treatable infection into a global threat ...

Growing concern over drugs fed to animals

September 19, 2011
Drugs fed to animals to promote growth and prevent diseases may play a key role in the emergence of antibiotic resistant bacteria, microbiologists said Sunday.

Drug-resistant infections: A new epidemic, and what you can do to help

November 10, 2011
(Medical Xpress)—Are you aware that colds, flu, most sore throats and bronchitis are caused by viruses? Did you know that antibiotics do not help fight viruses and that using them for viral infections only decreases their ...

Recommended for you

Screening could catch a quarter of hip fractures before they happen

December 15, 2017
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women - according to new research led by the University of East Anglia (UEA).

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.